Global Gallbladder Cancer Therapeutics Market 2019-2023 | Advent of Targeted Therapy to Boost Growth | Technavio

LONDON--()--The global gallbladder cancer therapeutics market is expected to post a CAGR of close to 5% during the period 2019-2023, according to the latest market research report by Technavio. Request a free sample report

Gallbladder cancer is a multifactorial, dependable progression, which makes it difficult to define the risk attributable to one factor. However, obesity is explicitly associated with the development of gallbladder cancer. There are several other risks that increase the chances of developing gallbladder cancer, which includes cholelithiasis, chronic inflammation, and gallbladder polyps. Such rising risk factors for gallbladder cancer are expected to fuel the gallbladder cancer therapeutics market growth during the forecast period.

Looking for more information on this market? Request a free sample report

As per Technavio, the advent of targeted therapy will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global gallbladder cancer therapeutics market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Gallbladder Cancer Therapeutics Market: Advent of Targeted Therapy

The gallbladder cancer therapeutics market is dominated by the use of chemotherapy drugs, which are associated with several adverse side effects. Thus, various vendors are conducting heavy research on developing novel therapies such as biologics with the mechanism of actions such as PD-1 inhibitors. Thus, the ongoing research on targeted therapies for the treatment of gallbladder cancer is expected to be a key trend that will fuel the market growth during the forecast period.

“Apart from the advent of targeted therapy, other factors such as the strong pipeline and strategic alliances will have a significant impact on the growth of the gallbladder cancer therapeutics market value during the forecast period,” says a senior analyst at Technavio.

Global Gallbladder Cancer Therapeutics Market: Segmentation Analysis

This market research report segments the global gallbladder cancer therapeutics market by type (combination therapy and monotherapy), and geographic regions (North America, Europe, Asia, and ROW).

The North American region led the gallbladder cancer therapeutics market in 2018, followed by Europe, Asia, and ROW, respectively. The growth of the gallbladder cancer therapeutics market share in North America can be attributed to factors such as the high sales of approved therapeutics and the increased R&D practices undertaken by major players in the region.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global gallbladder cancer therapeutics market is expected to post a CAGR of close to 5% during the period 2019-2023, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com